Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritis

By afschroeder • June 25, 2026

Karpouzas GA, Gonzalez-Gay MA, Pascual-Ramos V, Misra DP, Myasoedova E, Rantapää-Dahlqvist S, Sfikakis P, Dessein P, Hitchon CA, Galarza-Delgado D, Van Riel P, Semb AG, Hauge EM, Kitas GD, Ormseth SR; for An inTernationAl Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritis. RMD Open. 2026 Jun 24;12(2):e006929. doi: 10.1136/rmdopen-2026-006929. PMID: 42342284.

Tags: Anti-Citrullinated Protein Antibodies, Arthritis, Atherosclerosis, cardiovascular diseases, Harbor UCLA, Publications, Rheumatoid, rheumatoid factor, Rheumatology

A practical approach to Cardiopulmonary Exercise Testing: from functional evaluation to adapted exercise prescription

Neunhaeuserer D, Gevaert AB, Hansen D, Battista F, Bauer P, Davos CH, Ermolao A, Sanz-de la Garza M, Guazzi M, Howden EJ, Laukkanen J, Mueller-Stegner[...]

Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis

Tai D, Kim KI, Shah P, Park D, Kim L, Li J, Jung C, Guzman S, Brar G, Wu S, Castillo D. Impact of metastatic[...]

Investigating the Kidney-Gut-Brain Axis in CKD: Uremic Toxins and Brain Microhemorrhages

Zhao Y, Lee SM, Li W, Floriolli D, Chang P, Narasaki Y, You AS, Kalantar-Zadeh K, Rhee CM, Liu H, Tran T, Paganini-Hill A, Fisher[...]